Literature DB >> 27521892

M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance.

Divakar Sharma1, Manju Lata1, Mohammad Faheem2, Asad Ullah Khan2, Beenu Joshi3, Krishnamurthy Venkatesan1, Sangeeta Shukla4, Deepa Bisht5.   

Abstract

Tuberculosis is an infectious disease, caused by one of the most successful human pathogen, Mycobacterium tuberculosis. Aminoglycosides, Amikacin (AK) & Kanamycin (KM) are commonly used to treat drug resistant tuberculosis. They target the protein synthesis machinery by interacting with several steps of translation. Several explanations have been proposed to explain the mechanism of aminoglycoside resistance but still our information is inadequate. Iron storing/interacting proteins were found to be overexpressed in aminoglycosides resistant isolates. Iron assimilation and utilization in M. tuberculosis plays a crucial role in growth, virulence and latency. To establish the relationship of ferritin with AK & KM resistance ferritin (Rv3841/bfrB) was cloned, expressed and antimicrobial drug susceptibility testing (DST) was carried out. Rv3841/bfrB gene was cloned and expressed in E. coli BL21 using pQE2 expression vector. Etest results for DST against AK & KM showed that the minimum inhibitory concentration (MIC) of ferritin recombinant cells was changed. Recombinants showed two fold changes in MIC with AK and three fold with KM E-strips. Overexpression of ferritin reflect the MIC shift which might be playing a critical role in the survival of mycobacteria by inhibiting/modulating the effects of AK & KM. String analysis also suggests that ferritin interacted with few proteins which are directly and indirectly involved in M. tuberculosis growth, Iron assimilation, virulence, resistance, stresses and latency.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amikacin; Cloning; Etest; Expression; Ferritin; Kanamycin

Mesh:

Substances:

Year:  2016        PMID: 27521892     DOI: 10.1016/j.bbrc.2016.08.049

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association Study.

Authors:  Derek Conkle-Gutierrez; Calvin Kim; Sarah M Ramirez-Busby; Samuel J Modlin; Mikael Mansjö; Jim Werngren; Leen Rigouts; Sven E Hoffner; Faramarz Valafar
Journal:  Antimicrob Agents Chemother       Date:  2022-05-09       Impact factor: 5.938

2.  Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS.

Authors:  Divakar Sharma; Manju Lata; Rananjay Singh; Nirmala Deo; Krishnamurthy Venkatesan; Deepa Bisht
Journal:  Front Microbiol       Date:  2016-11-15       Impact factor: 5.640

3.  Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.

Authors:  Divakar Sharma; Yogesh K Dhuriya; Nirmala Deo; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-12-11       Impact factor: 5.640

4.  Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach.

Authors:  Divakar Sharma; Deepa Bisht
Journal:  Front Cell Infect Microbiol       Date:  2017-06-08       Impact factor: 5.293

5.  M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance.

Authors:  Divakar Sharma; Deepa Bisht
Journal:  Front Microbiol       Date:  2017-03-21       Impact factor: 5.640

6.  Mycobacterium tuberculosis Protein Rv3841 Activates Dendritic Cells and Contributes to a T Helper 1 Immune Response.

Authors:  Seunga Choi; Han-Gyu Choi; Ki-Won Shin; Yong Woo Back; Hye-Soo Park; Jae Hwi Lee; Hwa-Jung Kim
Journal:  J Immunol Res       Date:  2018-03-15       Impact factor: 4.818

7.  Mycobacterium abscessus subsp. massiliense mycma_0076 and mycma_0077 Genes Code for Ferritins That Are Modulated by Iron Concentration.

Authors:  Fábio M Oliveira; Adeliane C Da Costa; Victor O Procopio; Wanius Garcia; Juscemácia N Araújo; Roosevelt A Da Silva; Ana Paula Junqueira-Kipnis; André Kipnis
Journal:  Front Microbiol       Date:  2018-06-01       Impact factor: 5.640

8.  S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope.

Authors:  Padam Singh; Shashi Kant Kumar; Vineet Kumar Maurya; Basant Kumar Mehta; Hafsa Ahmad; Anil Kumar Dwivedi; Vinita Chaturvedi; Tejender S Thakur; Sudhir Sinha
Journal:  ACS Omega       Date:  2017-11-30

9.  Identification of Trombospondin-1 as a Novel Amelogenin Interactor by Functional Proteomics.

Authors:  Angela Capolupo; Chiara Cassiano; Agostino Casapullo; Giuseppina Andreotti; Maria V Cubellis; Andrea Riccio; Raffaele Riccio; Maria C Monti
Journal:  Front Chem       Date:  2017-10-09       Impact factor: 5.221

Review 10.  Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.

Authors:  H M Adnan Hameed; Md Mahmudul Islam; Chiranjibi Chhotaray; Changwei Wang; Yang Liu; Yaoju Tan; Xinjie Li; Shouyong Tan; Vincent Delorme; Wing W Yew; Jianxiong Liu; Tianyu Zhang
Journal:  Front Cell Infect Microbiol       Date:  2018-04-10       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.